PEOPLE - Changes at American Medical Systems:
This article was originally published in Clinica
Sam Humphries been named president and CEO of the former Pfizer subsidiary, American Medical Systems. He replaces David Booth who has resigned following the completion of the $130 million purchase of the urology device company by an ownership group led by investor firm Warburg, Pincus & Co. Mr Humphries, a member of the ownership group, held the same post at AMS between 1988 and 1991 before joining Optical Sensors, a US developer of arterial blood gas monitors. He will be succeeded as president and CEO of Optical by Paulita LaPlante, the company's vice-president of sales, marketing and business development.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.